Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 19/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 15/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL263225 | 0.86 | S1PR1 (0.50) | S1PR1S1PR3S1PR5 | |
| SCHEMBL262084 | 0.86 | S1PR1 (0.50) | S1PR1S1PR3S1PR5 | |
| SCHEMBL263803 | 0.82 | S1PR1 (0.34) | S1PR1S1PR3S1PR5 | |
| SCHEMBL262105 | 0.80 | S1PR1 (0.66) | S1PR1S1PR3S1PR5 | |
| SCHEMBL262404 | 0.80 | S1PR1 (0.66) | S1PR1S1PR3S1PR5 | |
| SCHEMBL27869684 | 0.72 | S1PR1 (0.40) | S1PR1S1PR3KDM4ENPC1ALDH1A1 | |
| SCHEMBL27869697 | 0.70 | S1PR1 (0.42) | S1PR1S1PR3KDM4ENPC1ALDH1A1 | |
| SCHEMBL14285688 | 0.70 | S1PR1 (0.43) | S1PR1S1PR3KDM4ENPC1ALDH1A1 | |
| SCHEMBL2294514 | 0.69 | S1PR1 (0.70) | S1PR1S1PR3 | |
| SCHEMBL2291664 | 0.69 | S1PR1 (0.70) | S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101528726-B | Thiophene derivatives as S1P1/EDG1 receptor agonists | ACTELION PHARMACEUTICALS LTD | 2012-11-14 | — | — | CN | disclosed |